Recursive Self-Improvement Now Has a Co-Evolving Evaluator: Cambridge-NVIDIA Paper Raises the Stakes
Recursive self-improvement AI now has a co-evolving evaluator: a Cambridge and NVIDIA preprint introduces the Red Queen Gödel ...
On July 4, 2026, Vitalik Buterin published the most consequential Ethereum protocol document in four years: an updated "Lean Ethereum" strawmap that commits the world's second-largest blockchain to ...
If you always dreamed of working in artificial intelligence, perhaps you studied computer science, or math. Who knows, maybe you did computational biology to better understand how to build a neural ...
XDA Developers on MSN
6 local LLMs I've used that prove they're not just smaller versions of cloud models
These local LLMs are changing the game in lots of fun ways.
What are Fugu and Fugu Ultra, the AI systems through which Japan's Sakana AI is betting on 'One Model To Command Them All' and claiming Mythos-level performance on some benchmarks?
By Kenny OlaSir: Intelligence is no more appreciated once it resides in arts and humanities. Graduates in arts and humanities are now made to appear like second class citizens in a country that once ...
The above button links to Coinbase. Yahoo Finance is not a broker-dealer or investment adviser and does not offer securities or cryptocurrencies for sale or facilitate trading. Coinbase pays us for ...
How Recursion is leading a new era of AI-driven drug discovery AI drug discovery is not a new phenomenon – but it is evolving at an almost dizzying pace. Recursion is one of the earliest innovators in ...
That admission is what some in the field call recursive self-improvement (RSI), the point at which large language models ...
The above button links to Coinbase. Yahoo Finance is not a broker-dealer or investment adviser and does not offer securities or cryptocurrencies for sale or facilitate trading. Coinbase pays us for ...
Recursion's co-founder and long-serving chief executive, Chris Gibson, has switched to the role of company chair, and will be succeeded in the CEO role by R&D and commercial head Najat Khan. The ...
Recursion is building an industrialized engine for medicine. It operates among biotech stocks, selling access to its proprietary platform and pursuing joint development with major partners like Roche ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results